Key facts
- Notable investors include Guizhou Financial Holdings Group, Guizhou Ventures Capital, Jiangsu New Supply and Marketing Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Guiwang Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Guiwang Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guiwang Biotechnology
Developer of edible fungi designed for the agriculture and planting industry. The company's products mainly focus on edible fungi factories integrating R&D, cultivation, technical training, processing, distribution, and product sales, which adopt an automated, intelligent, and entire industry chain production model to innovate and increase efficiency, providing customers with high-quality edible fungi.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Zunyi, China
- Founded
- 2016
- Employees
- 184
- Website
- gzguiwang.cn/
- Ownership
- Privately Held (backing)
Guiwang Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guiwang Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guiwang Biotechnology in its N-PORT filings yet. We sweep new filings monthly.